Skip Navigation

Annals of Oncology 2007 18(8):1421-1422; doi:10.1093/annonc/mdm367
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Farace, F
Right arrow Articles by Soria, J-C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farace, F
Right arrow Articles by Soria, J-C
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

letters to the editor

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells

The first 10% of the full text of this article appears below.

Antivascular therapies are currently intensively studied approaches in clinical oncology. Low molecular weight vascular disrupting agents (VDA) aim to cause rapid and selective shutdown of the established tumor vasculature, leading to massive cancer cell death in the central areas of tumor [1]. However, a common feature of VDA that is poorly understood is the sparing of a relatively intact viable rim at the periphery of the tumor. This viable rim leads to rapid regrowth of tumors . . . [Full Text of this Article]

F Farace1, C Massard2, E Borghi3, J-M Bidart1 and J-C Soria2,*

1 Translational Research Laboratory, Gustave Roussy Institute, 94805 Villejuif, France
2 Department of Medicine, Gustave Roussy Institute
3 Sanofi Aventis, 92165 Antony, France

* E-mail: soria@igr.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Y. Shaked, T. Tang, J. Woloszynek, L. G. Daenen, S. Man, P. Xu, S.-R. Cai, J. M. Arbeit, E. E. Voest, D. J. Chaplin, et al.
Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents
Cancer Res., October 1, 2009; 69(19): 7524 - 7528.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Taylor, J. Rossler, B. Geoerger, A. Laplanche, O. Hartmann, G. Vassal, and F. Farace
High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies
Clin. Cancer Res., July 15, 2009; 15(14): 4561 - 4571.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Mancuso, P. Antoniotti, J. Quarna, A. Calleri, C. Rabascio, C. Tacchetti, P. Braidotti, H.-K. Wu, A. J. Zurita, L. Saronni, et al.
Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses
Clin. Cancer Res., January 1, 2009; 15(1): 267 - 273.
[Abstract] [Full Text] [PDF]